glp-1 drug tirzepatide There may not be a safe off-ramp for some taking drugs, study suggests One GLP-1 Drug May Be

Both companies have built extensive patent thickets around their core molecules, with Novo Nordisk in particular pursuing aggressive filing strategies across new formulations, indications, and delivery methods

MSOT can produce three-dimensional (3D) images by capturing a stack of cross-sectional (chromatographic) images as a maximum intensity projection (MIP) image

The MDS-UPDRS and CDR-SB cannot cleanly separate symptomatic relief from disease modification, and EVOKE showed the converse failure mode, biomarker movement without clinical benefit, so future trials should anchor on objective measures such as dopamine-transporter SPECT, neurofilament light chain, and tau, amyloid, and neuroinflammation PET

Not right away

Diabetes is complicated enough by itself, and the American health-care system is one more obstacle to good health

Rev Dor